CDER pregnancy labeling (correction)
Executive Summary
FDA's pregnancy labeling initiative will remain under the Office of New Drugs following a reorganization that will create an Office of Counterterrorism & Pediatric Drug Development (formerly Office of Pediatric Drug Development & Program Initiatives) under the office of the CDER director. "The Pink Sheet" (July 1, p. 18) incorrectly referred to the pregnancy labeling initiative as a "pediatric" initiative...